Association between β2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope

Annals of the Rheumatic Diseases

Volumn 67, Issue 12, 2008, Pages 1759-1764

  Malysheva, O ^a   Pierer, M ^a   Wagner, U ^a,a   Wahle, M ^a   Baerwald, C G ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; EPITOPE; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GERMAN DEMOCRATIC REPUBLIC; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; SEVERITY OF ILLNESS INDEX;

EID: 49749083573     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2007.083782     Document Type: Article

References (43)

1. Baerwald CGO, Panayi GS. Neurohumoral mechanisms in rheumatoid arthritis. Scand J Rheumatol 1997;26:1-3.
2. Felten SY. Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 1992;52:25-48.
3. Landmann R. β-Adrenergic receptors are different in subpopulations of human circulating lymphocytes. J Recept Res 1984;4:37-50.
4. Radojcic T. Changes in β-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J Neurosi Res 1991;30:328-35.
5. Baerwald CG, Laufenberg M, Specht T, von Wiehert P, Burmester GR, Krause A. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of β2-adrenergic receptors. Br J Rheumatol 1997;36:1262-69.
6. Wahle M, Krause A, Kölker S, von Wiehert P, Baerwald CG. Intracellular cAMP and β2-adrenergic receptors on CD19+ lymphocytes in patients with rheumatoid arthritis. Ann NY Acad Sci 1999;876:309- 11.
7. McGraw DW. Polymorphisms of the 5′ leader cistron of the human β2-adrenergic receptor regulate receptor expression. J Clin Invest 1998;102:1927-32.
8. Chong LK. Influence of genetic polymorphisms in the β2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 2000;10:153-62.
9. Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, et al. cDNA for the human β2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987;84:46-50.
10. Green SA, Turki J, Hall IP, Liggett SB. Implications of genetic variability of human β2-adrenergic receptor structure. Pulm Pharmacol 1995;8:1-10.
11. Johnson M. The β-adrenoeeptor. Am J Respir Crit Care Med 1998;158:146-53.
12. Scott MG. Identification of novel polymorphisms within the promoter region of the human β2 adrenergic receptor gene. Br J Pharmacol 1999;126:841-44.
13. Timmermann B. Novel DNA sequence differences in the β2-adrenergic receptor gene promoter region. Hum Mutat 1998;11:343-44.
14. Brodde OE, Leineweber K. β2-Adrenoceptor gene polymorphisms. Pharmacogenet Genomics 2005;15:267-75.
15. Aynacioglu AS, Cascorbi I, Gungor K, Ozkur M, Bekir N, Roots I, et al. Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164IIe polymorphisms in the p2-adrenergic receptor among Turks. Br J Cl Pharmacol 1999;48:761-64.
16. Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH, et al. Frequency of functionally important β-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics 1999;9:511-16.
17. Liggett SB. β(2)-Adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med 2000;161:197-201.
18. Busjahn A, Li GH, Faulhaber HD, Rosenthal M, Becker A, Jeschke E, et al. β-2 Adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension 2000;35:555-60.
19. Ramsay CE, Hayden CM, Tiller KJ, Burton PR, Goldblatt J, Lesouef PN. Polymorphisms in the β2-adrenoreceptor gene are associated with decreased airway responsiveness. Clin Exp Allergy 1999;29:1195- 203.
20. Turki J, Pak J, Green SA, Martin RJ, Liggett SB. Genetic polymorphisms of the β2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995;95:1635-41.
21. Yamada K. Polymorphism in the 5′-leader cistron of the β2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 1999;84:1754-57.
22. Deichmann KA, Schmidt A, Heinzmann A, Kruse S, Forster J, Kuehr J. Association studies on β2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population. Clin Exp Allergy 1999;29:794-99.
23. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Ass 1949;140:659-62.
24. Straub RH, Baerwald CG, Wahle M, Janig W. Autonomic dysfunction in rheumatic diseases. Rheum Dis Clin North Am 2005;31:61-70.
25. Wahle M, Krause A, Pierer M, Hantzschel H, Baerwald CG. Immunopathogenesis of rheumatic diseases in the context of neuroendocrine interactions. Ann NY Acad Sci 2002;966:355-64.
26. Wagner U, Kaltenhauser S, Pierer M, Seidel W, Troltzsch M, Hantzschel H, et al. Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatology (Oxford) 2003;42:553-62.
27. Xu BY, Huang D, Pirskanen R, Lefvert AK. β2-Adrenergic receptor gene polymorphisms in myasthenia gravis (MG). Clin Exp Immunol 2000;119:156-60.
28. Wagner U, Kaltenhauser S, Sauer H, Arnold S, Seidel W, Hantzschel H, et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 1997;40:341-51.
29. Müller-Hilke B, Mitchison NA. The role of HLA promoting in autoimmunity. Curr Pharm Des 2006;12:3743-52.
30. Oliver JE, Worthington J, Siolman AJ. Genetic epidemiology of rheumatoid arthritis. Curr Opin Rheumatol 2006;18:141-6.
31. Pierer M, Kaltenhauser S, Arnold S, Wahle M, Baerwald C, Hantzschel H, et al. Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res Ther 2006;8:R75.
32. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007;66:803-6.
33. Baerwald CG, Mok CC, Tickly M, Lau CS, Wordsworth BP, Ollier B, et al. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients with rheumatoid arthritis. Z Rheumatol 2000;59:29-34.
34. Baerwald C, Wahle M, Ulrichs T, Jonas D, von Bierbrauer A, von Wiehert P, et al. Decreased density of β-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J Rheumatology 1992;19:204-10.
35. Wahle M, Kolker S, Krause A, Burmester GR, Baerwald CG. Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases. Ann Rheum Dis 2001;60:505-10
36. Xu B, Arlehag L. Rantapää-Dahlquist SB, Lefvert AK. β2-Adrenergic receptor gene single-nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden. Ann Rheum Dis 2005;64:773-6.
37. Baerwald CG, Burmester GR, Krause A. Interactions of autonomic nervous. neuroendocrine, and immune systems in rheumatoid arthritis. Rheum Dis Clin North Am 2000;26:841-57.
38. Wahle M, Hanefeld G, Brunn S, Straub RH, Wagner U. Krause A, et al. Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis. Arthritis Res Ther 2006;8:R138.
39. Härle P, Möbius D, Carr DJ, Schölmerich J, Straub RH. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum 2005;52:1305-13.
40. Kaltenhäuser S, Pierer M, Arnold S, Kamprad M, Baerwald C, Hantzschel H, et al. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis. Rheumatology (Oxford) 2007;46:100-4
41. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538- 41.
42. Busjahn A, Li GH, Faulhaber HD, Rosenthal M, Becker A, Jeschke E, et al. β-2 Adrenergic receptor gene variations, blood pressure, and heart size in normal twins Hypertension 2000;35:555-60.
43. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;4:2737-45.